|
US2013116335A1
|
|
Method for treating cancer with agents that bind phosphorylated CDC27
|
|
US2010122698A1
|
|
Neonatal airway stent
|
|
US2010056879A1
|
|
Method for maintaining homeostasis in a health care setting
|
|
US2009038621A1
|
|
Device and method for unilateral lung ventilation
|
|
US2010254973A1
|
|
Materials and Methods for Diagnosis of Asthma
|
|
US2008075750A1
|
|
Methods for producing three-dimensional tissue-engineered cardiac constructs and uses regarding same
|
|
US2007065836A1
|
|
Chromosome 1p36 polymorphisms and low bone mineral density
|
|
US2006191535A1
|
|
Treatment of decompression sickness with inhaled nitric oxide gas
|
|
US7166063B2
|
|
Brace compliance monitor
|
|
US7206638B2
|
|
Electrical current induced inhibition of bone growth
|
|
US6821259B2
|
|
Orthosis device
|
|
US6440065B1
|
|
Single-use disposable eyelid speculum, eye examination kit, and method for examining a patient's eye
|
|
US7074764B2
|
|
Treatment of intestinal epithelial cell malfunction, inflammation or damage with Hepatocyte growth factor
|
|
US6884777B1
|
|
Method for treating respiratory distress syndrome
|
|
US6630444B1
|
|
Intestinal function using leptin
|
|
US6432382B1
|
|
Measurement of gastric emptying using stable isotopes
|
|
US6475984B2
|
|
Administration of leptin
|
|
US6165736A
|
|
Method of detecting bacterial infection
|
|
US5913852A
|
|
Drain cannula
|
|
US5972887A
|
|
Treatment of intestinal epithelial cell malfunctions with Hepatocyte Growth Factor
|
